Annotation inferences using phylogenetic trees

Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt

Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma.

Inhibition of lipid transfer by a unique high density lipoprotein subclass containing an inhibitor protein.

Isolation and characterization of simple and complex lipoproteins containing apolipoprotein F from human plasma.

Regulation of lipid transfer between lipoproteins by an endogenous plasma protein: selective inhibition among lipoprotein classes.

Purification and molecular cloning of human apolipoprotein F.

Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F.

Lipid transfer inhibitor protein defines the participation of lipoproteins in lipid transfer reactions: CETP has no preference for cholesteryl esters in HDL versus LDL.

Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP).

CETP and lipid transfer inhibitor protein are uniquely affected by the negative charge density of the lipid and protein domains of LDL.

Control of cholesteryl ester transfer protein activity by sequestration of lipid transfer inhibitor protein in an inactive complex.

Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivo.

Conversion of lipid transfer inhibitor protein (apolipoprotein F) to its active form depends on LDL composition.

The effects of apolipoprotein F deficiency on high density lipoprotein cholesterol metabolism in mice.

Genetic manipulation of the ApoF/Stat2 locus supports an important role for type I interferon signaling in atherosclerosis.

Is there a link between proprotein convertase PC7 activity and human lipid homeostasis?

Architecture of the human interactome defines protein communities and disease networks.

Absolute quantitation of disease protein biomarkers in a single LC-MS acquisition using apolipoprotein F as an example.

ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters.

Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism.

Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.

Apolipoprotein F concentration, activity, and the properties of LDL controlling ApoF activation in hyperlipidemic plasma.

Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride-rich lipoprotein metabolism.

Affinage mechanistic annotation for APOF (human)

APOF (Q13790) sequence analysis — results